Condition
Prophylaxis of Organ Rejection
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00894088Not ApplicableCompletedPrimary
Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions
NCT00893919Not ApplicableCompletedPrimary
Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions
NCT00893542Not ApplicableCompletedPrimary
Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions
NCT00893958Not ApplicableCompletedPrimary
Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions
Showing all 4 trials